Mitral valve prolapse is a minor heart issue where blood can leak backward into the heart. Learn more about the causes, symptoms, and managing the condition.

Transcatheter Aortic Valve Reintervention: Long-Term Outcomes in an Asian Cohort Outcomes in Patients Discharged on OAC vs. DAPT After Left Atrial Appendage Occlusion Using a Fluoropolymer Coated ...

There is currently no way to stop calcification of the aortic valve. If all else fails, the valve must be replaced. To better understand the development of this common disease, researchers from ...

Abbott announced the FDA approved its transcatheter mitral valve replacement system for patients with severe mitral annular calcification at high surgical risk for open-heart surgery or ineligible ...

The FDA approved Abbott's Tendyne minimally invasive heart replacement for mitral valve disease that could disqualify patients for other approaches.

"Mitral annular calcification stiffens the structure of the mitral valve and can lead to mitral regurgitation or stenosis that disrupt the heart's ability to pump blood effectively.

For patients with severe MAC who are at high risk for open-heart surgery and whose mitral valve cannot be successfully repaired with the Abbott MitraClip™ device, Tendyne offers an alternative ...

Objective Intraoperative predictors of functional mitral valve (MV) stenosis after surgical repair of mitral regurgitation (MR) caused by prolapse remain poorly characterised. This study evaluated the ...

Mitral Valve Regurgitation: The valve doesn’t close completely, allowing blood to leak backward into the atrium. Mitral Valve Stenosis: The valve becomes too narrow, restricting proper blood flow.

Rheumatic mitral stenosis (RMS) is particularly common in developing countries (2). At present, the main treatment options for rheumatic mitral valve (MV) disease include MV valvuloplasty and MV ...

Whether transcatheter mitral-valve repair improves outcomes in patients with heart failure and functional mitral regurgitation is uncertain. We conducted a randomized, controlled trial involving pa ...

The new technology seems promising for patients with severe calcific mitral stenosis who cannot undergo surgery or TAVR, but more studies are needed.